MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Blood Processing, Blood Pumps, Diagnostics, Hemorrhage, Bleeding, Hemostatis, Transfusion, Intravenous (IV) Management
OrcaBio
Finance & Acquisitions: Orca Bio
Parents
OrcaBio
Children
2020: Orca Bio Emerges With Nearly $300 Million to Transform Allogeneic Cell Therapy
2020: Orca Bio Surfaces With $192M and Recipes for “Custom” Cell Therapies_xconomy
Orca Bio’s $192 million Series D financing was co-led by Lightspeed Venture Partners and an undisclosed investor. Other new and existing blue-chip investors also participated in the latest round, including 8VC, DCVC Bio, ND Capital, Mubadala Investment Company, Kaiser Foundation Hospitals, Kaiser Permanente Group Trust and IMRF.
Jumps
Key People: Orca Bio
Organization & Developments: Orca Bio